Detalhe da pesquisa
1.
Adverse effects of immunotherapies for multiple sclerosis: a network meta-analysis.
Cochrane Database Syst Rev
; 11: CD012186, 2023 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38032059
2.
Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis.
Cochrane Database Syst Rev
; 11: CD009333, 2016 11 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-27880972
3.
Comparative efficacy of interferon ß versus glatiramer acetate for relapsing-remitting multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 86(9): 1016-20, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25550414
4.
Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis.
Cochrane Database Syst Rev
; (7): CD009333, 2014 Jul 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-25062935
5.
The influence of fish farm activity on the social structure of the common bottlenose dolphin in Sardinia (Italy).
PeerJ
; 9: e10960, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33717695
6.
Training on adequate use of opioid analgesics in West and Central Africa: a neglected step on the way to access to essential medicines?
J Pharm Policy Pract
; 14(1): 104, 2021 Dec 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34886905
7.
Risk Management Plans: are they a tool for improving drug safety?
Eur J Clin Pharmacol
; 66(8): 785-90, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20577875
8.
Quality assessment of information about medications in primary care electronic patient record (EPR) systems.
Inform Prim Care
; 18(2): 109-16, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-21078233